Wen-Yi Wang1, Chang-Hao Yang1,2, Ta-Ching Chen1,3, Yi-Ting Hsieh1,2, Tzyy-Chang Ho1,2, Chung-May Yang1,2, Fang-Yu Liu1,4, Tso-Ting Lai5,6. 1. Department of Ophthalmology, National Taiwan University Hospital, Chung-Shan S. Rd, No 7, Taipei, 100, Taiwan. 2. College of Medicine, National Taiwan University, Taipei, Taiwan. 3. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. 4. Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. 5. Department of Ophthalmology, National Taiwan University Hospital, Chung-Shan S. Rd, No 7, Taipei, 100, Taiwan. b91401005@ntu.edu.tw. 6. Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan. b91401005@ntu.edu.tw.
Abstract
PURPOSE: To study serial changes in branching neovascular networks (BNN) by using optical coherence tomography angiography (OCTA) in patients with polypoidal choroidal vasculopathy (PCV) who underwent combined photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF) therapy. METHODS: In this retrospective study of 30 PCV patients who underwent combined therapy, OCTA images obtained at baseline and 1, 3, and 6 months after treatment were collected. The vessel area, vessel percentage area, average vessel length, and presence of polypoidal lesions on OCTA images as well as best-corrected visual acuity (BCVA), central retinal thickness (CRT), and central choroidal thickness (CCT) were recorded at each time point. RESULTS: The BNN- and polypoidal lesion-detection rates on baseline OCTA images were 100% and 71%, respectively. The vessel area decreased during the first 3 months, and increased 6 months post-treatment, showing significant differences from baseline (p = 0.031). The vessel percentage area also reduced 1 and 3 months post-treatment (p = 0.025) and increased 6 months post-treatment. Continuous polypoidal lesion regression was observed from 1 to 3 and 6 months post-treatment (p = 0.031, p = 0.004, p = 0.002, respectively, in comparison with baseline). Patients with a decreasing vessel area over 6 months showed greater choroidal thickness than those with increasing vessel area (p = 0.004). CONCLUSIONS: The BNN showed initial regression but were enlarged at 6 months after therapy. Patients showing continuous BNN regression showed a thicker choroid at baseline. This difference should be considered during treatment for PCV, and OCTA could be used for follow-up evaluations of PCV patients.
PURPOSE: To study serial changes in branching neovascular networks (BNN) by using optical coherence tomography angiography (OCTA) in patients with polypoidal choroidal vasculopathy (PCV) who underwent combined photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF) therapy. METHODS: In this retrospective study of 30 PCV patients who underwent combined therapy, OCTA images obtained at baseline and 1, 3, and 6 months after treatment were collected. The vessel area, vessel percentage area, average vessel length, and presence of polypoidal lesions on OCTA images as well as best-corrected visual acuity (BCVA), central retinal thickness (CRT), and central choroidal thickness (CCT) were recorded at each time point. RESULTS: The BNN- and polypoidal lesion-detection rates on baseline OCTA images were 100% and 71%, respectively. The vessel area decreased during the first 3 months, and increased 6 months post-treatment, showing significant differences from baseline (p = 0.031). The vessel percentage area also reduced 1 and 3 months post-treatment (p = 0.025) and increased 6 months post-treatment. Continuous polypoidal lesion regression was observed from 1 to 3 and 6 months post-treatment (p = 0.031, p = 0.004, p = 0.002, respectively, in comparison with baseline). Patients with a decreasing vessel area over 6 months showed greater choroidal thickness than those with increasing vessel area (p = 0.004). CONCLUSIONS: The BNN showed initial regression but were enlarged at 6 months after therapy. Patients showing continuous BNN regression showed a thicker choroid at baseline. This difference should be considered during treatment for PCV, and OCTA could be used for follow-up evaluations of PCV patients.
Authors: Tarek Alasil; Daniela Ferrara; Mehreen Adhi; Erika Brewer; Martin F Kraus; Caroline R Baumal; Joachim Hornegger; James G Fujimoto; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed Journal: Am J Ophthalmol Date: 2014-12-19 Impact factor: 5.258
Authors: Chui M Gemmy Cheung; Timothy Y Y Lai; Kelvin Teo; Paisan Ruamviboonsuk; Shih-Jen Chen; Judy E Kim; Fumi Gomi; Adrian H Koh; Gregg Kokame; Janice Marie Jordan-Yu; Federico Corvi; Alessandro Invernizzi; Yuichiro Ogura; Colin Tan; Paul Mitchell; Vishali Gupta; Jay Chhablani; Usha Chakravarthy; Srinivas R Sadda; Tien Y Wong; Giovanni Staurenghi; Won Ki Lee Journal: Ophthalmology Date: 2020-08-11 Impact factor: 12.079
Authors: Adrian Koh; Timothy Y Y Lai; Kanji Takahashi; Tien Y Wong; Lee-Jen Chen; Paisan Ruamviboonsuk; Colin S Tan; Chrystel Feller; Philippe Margaron; Tock H Lim; Won Ki Lee Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389